PUBLISHER: The Business Research Company | PRODUCT CODE: 1668543
PUBLISHER: The Business Research Company | PRODUCT CODE: 1668543
Renal denervation devices represent minimally invasive medical solutions designed for the treatment of resistant hypertension cases unresponsive to conventional interventions. These devices involve the insertion of a catheter into the renal arteries, employing radiofrequency energy to ablate sympathetic nerves within the vessel walls. This process enhances blood flow to the kidneys.
Key products in the renal denervation devices market include the Simplicity Renal Denervation System, EnligHTN, Vessix Renal Denervation System, Iberis Renal Sympathetic Denervation System, Paradise Renal Denervation System, and others. The Simplicity Renal Denervation System, for instance, utilizes a catheter and generator to deliver radiofrequency energy to the renal nerves. Various technologies, such as radiofrequency ablation, ultrasound energy-based RDN, brachytherapy, chemical ablation, and others, are employed by these devices. Target end-users include hospitals, cardiovascular research centers, and other medical facilities.
The renal denervation devices market research report is one of a series of new reports from The Business Research Company that provides renal denervation devices optical components market statistics, including renal denervation devices optical components industry global market size, regional shares, competitors with a renal denervation devices optical components market share, detailed renal denervation devices optical components market segments, market trends and opportunities, and any further data you may need to thrive in the renal denervation devices optical components industry. This renal denervation devices optical components market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The renal denervation devices market size has grown exponentially in recent years. It will grow from$0.55 billion in 2024 to $0.74 billion in 2025 at a compound annual growth rate (CAGR) of 34.0%. The growth in the historic period can be attributed to increased hypertension cases, clinical research and studies, increased in cardiovascular diseases, initial FDA approval and regulatory developments, market entry of renal denervation systems
The renal denervation devices market size is expected to see exponential growth in the next few years. It will grow to $2.28 billion in 2029 at a compound annual growth rate (CAGR) of 32.3%. The growth in the forecast period can be attributed to patient-centric approach, healthcare infrastructure development, growing awareness and acceptance, focus on minimally invasive therapies, market entry of new devices. Major trends in the forecast period include integration of artificial intelligence (ai) and machine learning, regulatory landscape changes, shift towards minimally invasive procedures, emphasis on clinical evidence, remote monitoring and telehealth integration.
The rising prevalence of hypertension is projected to stimulate the expansion of the renal denervation devices market in the coming years. Hypertension, commonly referred to as high blood pressure, occurs when the force of blood against the walls of the blood vessels remains consistently elevated. Renal denervation is a catheter-based procedure that has emerged as a promising treatment option for patients with resistant hypertension. This minimally invasive, investigational technique is designed to address hypertension that has not responded to standard medications. For instance, in May 2024, the Centers for Disease Control and Prevention, a US government agency, reported that high blood pressure was a contributing factor in or directly caused 685,875 deaths in the United States in 2022. Thus, the increasing prevalence of hypertension is expected to drive growth in the renal denervation devices market.
The growth of the renal denervation devices market is expected to be propelled by the rise in healthcare expenditures. Healthcare expenditures encompass all costs associated with providing health services, including support for family planning, nutrition programs, and emergency health assistance. Increased healthcare spending plays a pivotal role in fostering the adoption of renal denervation devices by providing financial support for both patients and healthcare systems. As an example, in June 2023, the Centers for Medicare & Medicaid Services reported a 2.7% increase in healthcare expenditure in the United States, totaling $4.3 trillion or $12,914 per person in 2021, constituting 18.3% of the nation's gross domestic product. This upward trend in healthcare spending further supports the growth trajectory of the renal denervation devices market.
Leading companies in the renal denervation devices market are concentrating on the development of ultrasound renal denervation (uRDN) to improve treatment effectiveness, minimize procedural complications, and offer a non-invasive alternative to conventional renal denervation methods. uRDN enhances renal denervation devices by facilitating precise, non-invasive energy delivery to the renal nerves, which effectively reduces blood pressure while safeguarding surrounding tissues, thereby increasing patient safety and comfort during the procedure. For example, in November 2023, Recor Medical Inc., a US-based medical technology firm, introduced the Paradise uRDN system, an innovative ultrasound renal denervation device aimed at treating hypertension in patients who have not reached blood pressure targets through standard lifestyle modifications and medications. This system incorporates hydrocooling technology to protect the renal artery during the procedure, marking a significant advancement in the renal denervation devices market by providing a novel, non-pharmacologic method for managing resistant hypertension and broadening treatment options for patients.
Companies operating in the renal denervation devices market are increasingly emphasizing the introduction of minimally invasive options to strengthen their competitive position. In November 2023, Recor Medical, another US-based medical device company, launched the Paradise Ultrasound Renal Denervation Therapy in the United States. This marked the first FDA-approved renal denervation therapy in the country, utilizing ultrasound technology to denervate sympathetic nerves surrounding the renal arteries and mitigating overactivity that can contribute to hypertension. The Paradise System has exhibited significant blood pressure reductions in clinical trials, representing a crucial advancement in hypertension management.
In April 2022, Clinical Accelerator, a UK-based full-service contract research organization, collaborated with Verve Medical to conduct a preliminary human feasibility study on an innovative medical device designed for individuals facing treatment-resistant hypertension. Verve Medical Inc., a US-based medical equipment manufacturer, is at the forefront of developing groundbreaking solutions to address the challenges associated with hypertension, further underscoring the industry's commitment to continuous innovation.
Major companies operating in the renal denervation devices market include Medtronic PLC, ReCor Medical Inc., Boston Scientific Corporation, Abbott Laboratories, Cordis Corporation, Terumo Corporation, Kona Medical Inc., St. Jude Medical LLC, Johnson & Johnson, Mercator MedSystems Inc., Symple Surgical Inc., Ablative Solutions Inc., Cardiosonic Ltd., Renal Dynamics Ltd., Vesalio LLC, Atricure Inc., Biosense Webster Inc., Biotronik SE & Co. KG, Cook Medical LLC, Hansen Medical Inc., Merit Medical Systems Inc., AngioDynamics Inc., Covidien Ltd., Volcano Corporation, Edwards Lifesciences Corporation, InnoVein Inc., Teleflex Incorporated, Medinol Ltd., Oscor Inc., Balton Sp. z o.o.
Europe was the largest region in the renal denervation devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global renal denervation devices market report during the forecast period. The regions covered in the renal denervation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the renal denervation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The renal denervation devices market consists of sales of products including a single electrode, multi-electrode, irrigated catheter, and others. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Renal Denervation Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on renal denervation devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for renal denervation devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The renal denervation devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.